Mereo BioPharma Group PLC Share Price London S.E.
Equities
GB00BZ4G2K23
Biotechnology & Medical Research
Sales 2024 * | 2.75Cr 3.45Cr 288.22Cr | Sales 2025 * | 1.25Cr 1.57Cr 131.01Cr | Capitalization | 33Cr 42Cr 3.47TCr |
---|---|---|---|---|---|
Net income 2024 * | -80L -1Cr -84Cr | Net income 2025 * | -2.8Cr -3.52Cr -293.46Cr | EV / Sales 2024 * | 7.37 x |
Net cash position 2024 * | 13Cr 16Cr 1.35TCr | Net cash position 2025 * | 14Cr 18Cr 1.49TCr | EV / Sales 2025 * | 15.1 x |
P/E ratio 2024 * |
-315
x | P/E ratio 2025 * |
-63.9
x | Employees | - |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 46.94% |
Managers | Title | Age | Since |
---|---|---|---|
John P. Richard
FOU | Founder | 66 | 01/15/01 |
Founder | 64 | 10/15/10 | |
Charles Sermon
FOU | Founder | 55 | 01/15/01 |
Members of the board | Title | Age | Since |
---|---|---|---|
Michael Wyzga
CHM | Chairman | 69 | 23/19/23 |
Director/Board Member | - | 10/22/10 | |
Director/Board Member | 59 | 23/19/23 |
1st Jan change | Capi. | |
---|---|---|
+5.66% | 11TCr | |
+11.23% | 11TCr | |
-0.38% | 2.23TCr | |
-12.15% | 2.21TCr | |
-7.66% | 1.87TCr | |
-36.52% | 1.76TCr | |
-10.09% | 1.69TCr | |
+3.33% | 1.38TCr | |
+36.58% | 1.25TCr |